EU
AMGN icon

Emory University’s Amgen AMGN Stock Holding History

Emory University’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-137
Closed -$15K – 9
2013
Q4 		$15K Hold
137
– – 0.01% 24
2013
Q3 		$15K Hold
137
– – 0.01% 22
2013
Q2 		$14K Buy
+137
New +$14.2K 0.01% 18

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Emory University's AMGN Position: Q1 2014 in Review

Emory University sold out of Amgen (AMGN) in Q1 2014, closing a stake of 137 shares — an estimated $15K sold.

Emory University first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $15K in Q4 2013. 1,180 funds tracked by Wall St. Rank hold AMGN as of Q1 2014.

  • Emory University reported no remaining Amgen position as of Q1 2014 after selling out during the quarter.
  • Emory University sold 137 Amgen shares in Q1 2014, an estimated $15K.
  • Emory University first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
  • Emory University's Amgen position peaked at $15K in Q4 2013.
  • 1,180 funds tracked by Wall St. Rank held Amgen as of Q1 2014.

Based on Emory University's 13F filing for Q1 2014, filed 13 May 2014.